Click here Linkedin to follow the activities, news and job opportunities at ART-TG

Ecoutez Anne Galy sur France Culture. Science Chrono, émission d’Antoine Beauchamp, diffusée le Samedi 8 Octobre 2023.

POST-DOCTORAL POSITION NEW - APPLY ! HEAD OF BIOPRODUCTION https://www.art-tg.com/jobs

https://www.genopole.fr/temps-forts/agenda/symposium-cart-cells-art-tg/ #inserm #ART-TG #genopole

Galy and co-authors have recently published in Human Gene Therapy, a review of recent strategies using gene therapy and genetic vaccines...

Evaluation of diversity indices to estimate clonal dominance in gene therapy studies by Guillaume Corre and Anne Galy. Molecular Therapy...

Mai 19, 2023 ART-TG / Inserm is proud to be part of the gene therapy biocluster GENOTHER, one of the 5 bioclusters announced by the...

02 Feb 2023. ART-TG is recruiting a head for its Bioproduction unit, a great opportunity to contribute to exciting research in gene...

Visite de Sylvie Retailleau, Ministre de la Recherche, de l'Enseignement Supérieur et de l'Innovatio, accompagnée de Gilles Bloch,...

Presentation of poster 504 by Dr. J. Doms ART-TG at ESGCT Vaccine technologies and Infectious Diseases. Rrom Pentland 8:30-10:40 "A...

ART-TG contributed to lentiviral standardization, improving analytical methods. Corre et al. Gene Therapy (2022) 29:536–543 #genetherapy,...

ART-TG contributed to this recent review by Donnadieu et al. in Journal for Immunotherapy of Cancer, https://jitc.bmj.com/content/10/5/e0...

ART-TG recruits engineers and managers for its projects. Please check the JOBS annoucements

ASMA project: Acoustic Solutions for Manufacturing Advanced Therapies

https://www.youtube.com/watch?v=6jzlHz2Vbrw

ART-TG is pleased to announce its collaboration with WhiteLab Genomics on the development of artificial intelligence to improve the...

. ..of gene therapies for severe immune deficiencies. In this consortium, ART-TG will bring its expertise on the quality control of...

Development of CAR-T cell therapies to fight cancer. Read the press release.